Report Thumbnail
Product Code LP0912617528LF
Published Date 2026/7/14
English141 PagesGlobal

Global Medical Device Microbial Testing Service Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0912617528LF
Published Date 2026/7/14
English 141 PagesGlobal

Global Medical Device Microbial Testing Service Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global medical device microbial testing service market, projecting steady growth through 2032. Driven by stringent regulatory requirements and the increasing complexity of implantable and sterile devices, the market encompasses critical services such as bioburden, sterility, and endotoxin testing. The study examines key segments, testing techniques, and regional dynamics, while profiling major global laboratory groups and specialized service providers shaping the industry's competitive landscape.

Related Questions

US$ 802 million in 2025; US$ 1230 million in 2032

6.4% CAGR (2026 to 2032)

Nelson Labs, Eurofins Scientific SE, NAMSA, STERIS AST, Charles River Laboratories, TÜV SÜD AG, SGS SA, UL Solutions, Element Materials Technology, Labcorp, Cormica, BSL BIOSERVICE, HygCen Germany, Medistri, Pacific BioLabs, Microbac, WuXi AppTec Medical Device Testing Center, CTI, Pony Testing, CVC Testing, CAS Testing, Vimta Labs, Korea Testing & Research Institute, Korea Testing Laboratory, Japan Gas Co., Ltd., SHI-ATEX

rising sterile device volumes, more complex minimally invasive and implantable devices, stricter expectations for reusable-device cleaning and disinfection validation


Summary

Market Overview

The global Medical Device Microbial Testing Service market is projected to grow from US$ 802 million in 2025 to US$ 1230 million in 2032, representing a compound annual growth rate (CAGR) of 6.4% from 2026 to 2032.

Service Definition

Medical Device Microbiological Testing Services encompass outsourced laboratory, Contract Research Organization (CRO), Testing, Inspection and Certification (TIC), and sterilization-validation testing services. These services are designed to evaluate and control microbial contamination risks associated with:

  • Medical devices and device components
  • Packaging systems
  • Manufacturing environments
  • Sterilization processes
  • Reusable-device reprocessing workflows

Market Dynamics & Strategic Insights

Nature of the Market

Rather than a generic laboratory testing category, Medical Device Microbiological Testing Services function as a regulatory-driven quality and sterility assurance service market. Demand is driven by the necessity to demonstrate control over microbial contamination risks throughout the following stages:

  • Device development
  • Sterilization validation
  • Routine release
  • Manufacturing change control
  • Post-validation maintenance

Demand Drivers and Complexity

  • Stable Demand Segments: Bioburden testing, sterility testing, and bacterial endotoxin testing.
  • High-Complexity Segments: Reusable-device reprocessing validation, sterilization process validation, microbial barrier testing, package integrity, and contamination investigations.

Supplier Evaluation Criteria

Because test outcomes directly impact product release, sterilization validation, registration submissions, and quality system compliance, manufacturers prioritize the following factors over price:

  • Accreditation and regulatory familiarity
  • Method suitability experience
  • Data integrity
  • Turnaround reliability
  • Historical device project expertise

Market Outlook & Future Trends

Growth Projections

The global market is expected to grow at a mid-single-digit pace through 2032. Key drivers include:

  • Rising volumes of sterile devices
  • Increasing complexity of minimally invasive and implantable devices
  • Stricter requirements for reusable-device cleaning and disinfection validation
  • Regional supply chain diversification

Industry Evolution

  • Consolidation: Large groups are expected to continue expanding laboratory capacity, acquiring specialized microbiology laboratories, and integrating sterilization, testing, and regulatory support.
  • Technological Impact: Rapid microbiological methods, automated identification, recombinant endotoxin methods, and laboratory digitalization are expected to improve throughput and data reliability. These technologies are projected to reshape service delivery rather than eliminate the need for third-party testing.
  • Competitive Variables: Success will be defined by global laboratory coverage, validated methods, regulatory acceptance, technical depth in complex devices, and the capability to support multi-region device launches.

Market Segmentation

By Type

  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
  • Others

By Testing Techniques

  • Traditional Culture Methods
  • Molecular Biology Methods
  • Mass Spectrometry
  • Others

By Testing Phases

  • Microbiological Testing during R&D
  • Microbiological Testing during Production
  • Microbiological Testing for Finished Product Release
  • Post-Market Microbiological Testing

By Application

  • Implantable Medical Devices Industry
  • Interventional Medical Devices Industry
  • In Vitro Diagnostic (IVD) Medical Devices Industry
  • Others

By Region

  • Americas: United States, Canada, Mexico, Brazil
  • APAC: China, Japan, Korea, Southeast Asia, India, Australia
  • Europe: Germany, France, UK, Italy, Russia
  • Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Supply Side Analysis

The market is led by large North American and European laboratory, CRO, TIC, and sterilization-validation groups, supported by regional specialists and growing domestic providers in China, India, Japan, and South Korea.

Key Players & Market Tiers

Global/Multi-Regional Broad-Service Tier:

  • Nelson Labs
  • Eurofins
  • NAMSA
  • STERIS AST
  • Charles River
  • TÜV SÜD
  • SGS
  • UL Solutions
  • Element
  • Labcorp

Specialized Technical & Regional Support Tier:

  • Cormica
  • BSL BIOSERVICE
  • HygCen
  • Medistri
  • Pacific BioLabs
  • Microbac

Key Chinese Providers (Crucial for local registration, production QC, and export-oriented manufacturers):

  • WuXi AppTec Medical Device Testing Center
  • CTI
  • Pony Testing
  • CVC Testing
  • CAS Testing

Other Profiled Companies:

  • Vimta Labs
  • Korea Testing & Research Institute
  • Korea Testing Laboratory
  • Japan Gas Co., Ltd.
  • SHI-ATEX

About the Report

The "Medical Device Microbial Testing Service Industry Forecast" by LPI (LP Information) provides a comprehensive analysis of the global landscape. It reviews total world sales in 2025 and provides detailed projections from 2026 through 2032. The report covers:

  • Revenue and market share analysis
  • Company formation, latest developments, and M&A activity
  • Corporate strategies, including portfolios, market entry, and geographic footprints
  • Nuanced views based on hundreds of bottom-up qualitative and quantitative market inputs

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Medical Device Microbial Testing Service Market Size (2021-2032)
      • 2.1.2 Medical Device Microbial Testing Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
      • 2.1.3 World Current & Future Analysis for Medical Device Microbial Testing Service by Country/Region (2021, 2025 & 2032)
    • 2.2 Medical Device Microbial Testing Service Segment by Type
      • 2.2.1 Bioburden Testing
      • 2.2.2 Sterility Testing
      • 2.2.3 Bacterial Endotoxin Testing
      • 2.2.4 Others
      • 2.2.5 Medical Device Microbial Testing Service Market Size by Type
        • 2.2.5.1 Medical Device Microbial Testing Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
        • 2.2.5.2 Global Medical Device Microbial Testing Service Market Size Market Share by Type (2021-2026)
    • 2.3 Medical Device Microbial Testing Service Segment by Testing Techniques
      • 2.3.1 Traditional Culture Methods
      • 2.3.2 Molecular Biology Methods
      • 2.3.3 Mass Spectrometry
      • 2.3.4 Others
      • 2.3.5 Medical Device Microbial Testing Service Market Size by Testing Techniques
        • 2.3.5.1 Medical Device Microbial Testing Service Market Size CAGR by Testing Techniques (2021 VS 2025 VS 2032)
        • 2.3.5.2 Global Medical Device Microbial Testing Service Market Size Market Share by Testing Techniques (2021-2026)
    • 2.4 Medical Device Microbial Testing Service Segment by Testing Phases
      • 2.4.1 Microbiological Testing during R&D
      • 2.4.2 Microbiological Testing during Production
      • 2.4.3 Microbiological Testing for Finished Product Release
      • 2.4.4 Post-Market Microbiological Testing
      • 2.4.5 Medical Device Microbial Testing Service Market Size by Testing Phases
        • 2.4.5.1 Medical Device Microbial Testing Service Market Size CAGR by Testing Phases (2021 VS 2025 VS 2032)
        • 2.4.5.2 Global Medical Device Microbial Testing Service Market Size Market Share by Testing Phases (2021-2026)
    • 2.5 Medical Device Microbial Testing Service Segment by Application
      • 2.5.1 Implantable Medical Devices Industry
      • 2.5.2 Interventional Medical Devices Industry
      • 2.5.3 In Vitro Diagnostic (IVD) Medical Devices Industry
      • 2.5.4 Others
      • 2.5.5 Medical Device Microbial Testing Service Market Size by Application
        • 2.5.5.1 Medical Device Microbial Testing Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
        • 2.5.5.2 Global Medical Device Microbial Testing Service Market Size Market Share by Application (2021-2026)
  • 3 Medical Device Microbial Testing Service Market Size by Player

    • 3.1 Medical Device Microbial Testing Service Market Size Market Share by Player
      • 3.1.1 Global Medical Device Microbial Testing Service Revenue by Player (2021-2026)
      • 3.1.2 Global Medical Device Microbial Testing Service Revenue Market Share by Player (2021-2026)
    • 3.2 Global Medical Device Microbial Testing Service Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Medical Device Microbial Testing Service by Region

    • 4.1 Medical Device Microbial Testing Service Market Size by Region (2021-2026)
    • 4.2 Global Medical Device Microbial Testing Service Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Medical Device Microbial Testing Service Market Size Growth (2021-2026)
    • 4.4 APAC Medical Device Microbial Testing Service Market Size Growth (2021-2026)
    • 4.5 Europe Medical Device Microbial Testing Service Market Size Growth (2021-2026)
    • 4.6 Middle East & Africa Medical Device Microbial Testing Service Market Size Growth (2021-2026)
  • 5 Americas

    • 5.1 Americas Medical Device Microbial Testing Service Market Size by Country (2021-2026)
    • 5.2 Americas Medical Device Microbial Testing Service Market Size by Type (2021-2026)
    • 5.3 Americas Medical Device Microbial Testing Service Market Size by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Medical Device Microbial Testing Service Market Size by Region (2021-2026)
    • 6.2 APAC Medical Device Microbial Testing Service Market Size by Type (2021-2026)
    • 6.3 APAC Medical Device Microbial Testing Service Market Size by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Medical Device Microbial Testing Service Market Size by Country (2021-2026)
    • 7.2 Europe Medical Device Microbial Testing Service Market Size by Type (2021-2026)
    • 7.3 Europe Medical Device Microbial Testing Service Market Size by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Medical Device Microbial Testing Service by Region (2021-2026)
    • 8.2 Middle East & Africa Medical Device Microbial Testing Service Market Size by Type (2021-2026)
    • 8.3 Middle East & Africa Medical Device Microbial Testing Service Market Size by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Medical Device Microbial Testing Service Market Forecast

    • 10.1 Global Medical Device Microbial Testing Service Forecast by Region (2027-2032)
      • 10.1.1 Global Medical Device Microbial Testing Service Forecast by Region (2027-2032)
      • 10.1.2 Americas Medical Device Microbial Testing Service Forecast
      • 10.1.3 APAC Medical Device Microbial Testing Service Forecast
      • 10.1.4 Europe Medical Device Microbial Testing Service Forecast
      • 10.1.5 Middle East & Africa Medical Device Microbial Testing Service Forecast
    • 10.2 Americas Medical Device Microbial Testing Service Forecast by Country (2027-2032)
      • 10.2.1 United States Market Medical Device Microbial Testing Service Forecast
      • 10.2.2 Canada Market Medical Device Microbial Testing Service Forecast
      • 10.2.3 Mexico Market Medical Device Microbial Testing Service Forecast
      • 10.2.4 Brazil Market Medical Device Microbial Testing Service Forecast
    • 10.3 APAC Medical Device Microbial Testing Service Forecast by Region (2027-2032)
      • 10.3.1 China Medical Device Microbial Testing Service Market Forecast
      • 10.3.2 Japan Market Medical Device Microbial Testing Service Forecast
      • 10.3.3 Korea Market Medical Device Microbial Testing Service Forecast
      • 10.3.4 Southeast Asia Market Medical Device Microbial Testing Service Forecast
      • 10.3.5 India Market Medical Device Microbial Testing Service Forecast
      • 10.3.6 Australia Market Medical Device Microbial Testing Service Forecast
    • 10.4 Europe Medical Device Microbial Testing Service Forecast by Country (2027-2032)
      • 10.4.1 Germany Market Medical Device Microbial Testing Service Forecast
      • 10.4.2 France Market Medical Device Microbial Testing Service Forecast
      • 10.4.3 UK Market Medical Device Microbial Testing Service Forecast
      • 10.4.4 Italy Market Medical Device Microbial Testing Service Forecast
      • 10.4.5 Russia Market Medical Device Microbial Testing Service Forecast
    • 10.5 Middle East & Africa Medical Device Microbial Testing Service Forecast by Region (2027-2032)
      • 10.5.1 Egypt Market Medical Device Microbial Testing Service Forecast
      • 10.5.2 South Africa Market Medical Device Microbial Testing Service Forecast
      • 10.5.3 Israel Market Medical Device Microbial Testing Service Forecast
      • 10.5.4 Turkey Market Medical Device Microbial Testing Service Forecast
    • 10.6 Global Medical Device Microbial Testing Service Forecast by Type (2027-2032)
    • 10.7 Global Medical Device Microbial Testing Service Forecast by Application (2027-2032)
      • 10.7.1 GCC Countries Market Medical Device Microbial Testing Service Forecast
  • 11 Key Players Analysis

    • 11.1 Nelson Labs
      • 11.1.1 Nelson Labs Company Information
      • 11.1.2 Nelson Labs Medical Device Microbial Testing Service Product Offered
      • 11.1.3 Nelson Labs Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.1.4 Nelson Labs Main Business Overview
      • 11.1.5 Nelson Labs Latest Developments
    • 11.2 Eurofins Scientific SE
      • 11.2.1 Eurofins Scientific SE Company Information
      • 11.2.2 Eurofins Scientific SE Medical Device Microbial Testing Service Product Offered
      • 11.2.3 Eurofins Scientific SE Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.2.4 Eurofins Scientific SE Main Business Overview
      • 11.2.5 Eurofins Scientific SE Latest Developments
    • 11.3 NAMSA
      • 11.3.1 NAMSA Company Information
      • 11.3.2 NAMSA Medical Device Microbial Testing Service Product Offered
      • 11.3.3 NAMSA Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.3.4 NAMSA Main Business Overview
      • 11.3.5 NAMSA Latest Developments
    • 11.4 STERIS AST
      • 11.4.1 STERIS AST Company Information
      • 11.4.2 STERIS AST Medical Device Microbial Testing Service Product Offered
      • 11.4.3 STERIS AST Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.4.4 STERIS AST Main Business Overview
      • 11.4.5 STERIS AST Latest Developments
    • 11.5 WuXi AppTec Medical Device Testing Center
      • 11.5.1 WuXi AppTec Medical Device Testing Center Company Information
      • 11.5.2 WuXi AppTec Medical Device Testing Center Medical Device Microbial Testing Service Product Offered
      • 11.5.3 WuXi AppTec Medical Device Testing Center Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.5.4 WuXi AppTec Medical Device Testing Center Main Business Overview
      • 11.5.5 WuXi AppTec Medical Device Testing Center Latest Developments
    • 11.6 Charles River Laboratories
      • 11.6.1 Charles River Laboratories Company Information
      • 11.6.2 Charles River Laboratories Medical Device Microbial Testing Service Product Offered
      • 11.6.3 Charles River Laboratories Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.6.4 Charles River Laboratories Main Business Overview
      • 11.6.5 Charles River Laboratories Latest Developments
    • 11.7 TÜV SÜD AG
      • 11.7.1 TÜV SÜD AG Company Information
      • 11.7.2 TÜV SÜD AG Medical Device Microbial Testing Service Product Offered
      • 11.7.3 TÜV SÜD AG Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.7.4 TÜV SÜD AG Main Business Overview
      • 11.7.5 TÜV SÜD AG Latest Developments
    • 11.8 SGS SA
      • 11.8.1 SGS SA Company Information
      • 11.8.2 SGS SA Medical Device Microbial Testing Service Product Offered
      • 11.8.3 SGS SA Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.8.4 SGS SA Main Business Overview
      • 11.8.5 SGS SA Latest Developments
    • 11.9 UL Solutions
      • 11.9.1 UL Solutions Company Information
      • 11.9.2 UL Solutions Medical Device Microbial Testing Service Product Offered
      • 11.9.3 UL Solutions Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.9.4 UL Solutions Main Business Overview
      • 11.9.5 UL Solutions Latest Developments
    • 11.10 Element Materials Technology
      • 11.10.1 Element Materials Technology Company Information
      • 11.10.2 Element Materials Technology Medical Device Microbial Testing Service Product Offered
      • 11.10.3 Element Materials Technology Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.10.4 Element Materials Technology Main Business Overview
      • 11.10.5 Element Materials Technology Latest Developments
    • 11.11 Labcorp
      • 11.11.1 Labcorp Company Information
      • 11.11.2 Labcorp Medical Device Microbial Testing Service Product Offered
      • 11.11.3 Labcorp Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.11.4 Labcorp Main Business Overview
      • 11.11.5 Labcorp Latest Developments
    • 11.12 Cormica
      • 11.12.1 Cormica Company Information
      • 11.12.2 Cormica Medical Device Microbial Testing Service Product Offered
      • 11.12.3 Cormica Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.12.4 Cormica Main Business Overview
      • 11.12.5 Cormica Latest Developments
    • 11.13 CTI Testing
      • 11.13.1 CTI Testing Company Information
      • 11.13.2 CTI Testing Medical Device Microbial Testing Service Product Offered
      • 11.13.3 CTI Testing Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.13.4 CTI Testing Main Business Overview
      • 11.13.5 CTI Testing Latest Developments
    • 11.14 Pacific BioLabs
      • 11.14.1 Pacific BioLabs Company Information
      • 11.14.2 Pacific BioLabs Medical Device Microbial Testing Service Product Offered
      • 11.14.3 Pacific BioLabs Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.14.4 Pacific BioLabs Main Business Overview
      • 11.14.5 Pacific BioLabs Latest Developments
    • 11.15 Microbac
      • 11.15.1 Microbac Company Information
      • 11.15.2 Microbac Medical Device Microbial Testing Service Product Offered
      • 11.15.3 Microbac Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.15.4 Microbac Main Business Overview
      • 11.15.5 Microbac Latest Developments
    • 11.16 Pony Testing
      • 11.16.1 Pony Testing Company Information
      • 11.16.2 Pony Testing Medical Device Microbial Testing Service Product Offered
      • 11.16.3 Pony Testing Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.16.4 Pony Testing Main Business Overview
      • 11.16.5 Pony Testing Latest Developments
    • 11.17 CVC Testing
      • 11.17.1 CVC Testing Company Information
      • 11.17.2 CVC Testing Medical Device Microbial Testing Service Product Offered
      • 11.17.3 CVC Testing Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.17.4 CVC Testing Main Business Overview
      • 11.17.5 CVC Testing Latest Developments
    • 11.18 BSL BIOSERVICE
      • 11.18.1 BSL BIOSERVICE Company Information
      • 11.18.2 BSL BIOSERVICE Medical Device Microbial Testing Service Product Offered
      • 11.18.3 BSL BIOSERVICE Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.18.4 BSL BIOSERVICE Main Business Overview
      • 11.18.5 BSL BIOSERVICE Latest Developments
    • 11.19 HygCen Germany
      • 11.19.1 HygCen Germany Company Information
      • 11.19.2 HygCen Germany Medical Device Microbial Testing Service Product Offered
      • 11.19.3 HygCen Germany Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.19.4 HygCen Germany Main Business Overview
      • 11.19.5 HygCen Germany Latest Developments
    • 11.20 Vimta Labs
      • 11.20.1 Vimta Labs Company Information
      • 11.20.2 Vimta Labs Medical Device Microbial Testing Service Product Offered
      • 11.20.3 Vimta Labs Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.20.4 Vimta Labs Main Business Overview
      • 11.20.5 Vimta Labs Latest Developments
    • 11.21 Medistri
      • 11.21.1 Medistri Company Information
      • 11.21.2 Medistri Medical Device Microbial Testing Service Product Offered
      • 11.21.3 Medistri Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.21.4 Medistri Main Business Overview
      • 11.21.5 Medistri Latest Developments
    • 11.22 Korea Testing & Research Institute
      • 11.22.1 Korea Testing & Research Institute Company Information
      • 11.22.2 Korea Testing & Research Institute Medical Device Microbial Testing Service Product Offered
      • 11.22.3 Korea Testing & Research Institute Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.22.4 Korea Testing & Research Institute Main Business Overview
      • 11.22.5 Korea Testing & Research Institute Latest Developments
    • 11.23 Korea Testing Laboratory
      • 11.23.1 Korea Testing Laboratory Company Information
      • 11.23.2 Korea Testing Laboratory Medical Device Microbial Testing Service Product Offered
      • 11.23.3 Korea Testing Laboratory Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.23.4 Korea Testing Laboratory Main Business Overview
      • 11.23.5 Korea Testing Laboratory Latest Developments
    • 11.24 Japan Gas Co., Ltd.
      • 11.24.1 Japan Gas Co., Ltd. Company Information
      • 11.24.2 Japan Gas Co., Ltd. Medical Device Microbial Testing Service Product Offered
      • 11.24.3 Japan Gas Co., Ltd. Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.24.4 Japan Gas Co., Ltd. Main Business Overview
      • 11.24.5 Japan Gas Co., Ltd. Latest Developments
    • 11.25 SHI-ATEX
      • 11.25.1 SHI-ATEX Company Information
      • 11.25.2 SHI-ATEX Medical Device Microbial Testing Service Product Offered
      • 11.25.3 SHI-ATEX Medical Device Microbial Testing Service Revenue, Gross Margin and Market Share (2021-2026)
      • 11.25.4 SHI-ATEX Main Business Overview
      • 11.25.5 SHI-ATEX Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.